Description

FOXO4-DRI (FOXO4-D-Retro-Inverso Peptide)

Description

FOXO4-DRI is a synthetic peptide designed to disrupt the interaction between the transcription factor FOXO4 and the tumor suppressor protein p53.
It is an investigational compound studied for its potential ability to selectively eliminate senescent (aging) cells, making it a subject of growing interest in aging, longevity, and regenerative medicine research.

Key benefits (research findings)

Studied for its potential to selectively target and eliminate senescent cells in preclinical models.
May support healthy tissue function by reducing the accumulation of senescent cells associated with aging.
Investigated for potential benefits in tissue regeneration, physical function, and age-related biological processes.
Research suggests it may improve markers of healthspan in animal models, though human data remain limited.

Who it’s for

Researchers investigating cellular senescence, aging biology, regenerative medicine, and longevity pathways.
Intended strictly for laboratory and investigational use; not for individual or unsupervised administration.

Suggested use

Utilized exclusively in controlled research environments according to established study protocols.
Experimental dosing, administration methods, and treatment schedules vary depending on the research design and objectives.

Safety and storage

Safety data in humans are limited, and the compound remains investigational.
Proper laboratory safety procedures, sterile handling techniques, and institutional protocols should always be followed.
Store according to manufacturer or protocol recommendations (typically refrigerated and protected from light) to maintain peptide stability.

Quick facts

Mechanism: disrupts the FOXO4-p53 interaction to promote apoptosis of senescent cells in experimental models.
Status: investigational senolytic peptide; not approved for therapeutic use.
Studied for: cellular senescence, healthy aging, regenerative medicine, and longevity research.

Research Use Only Disclaimer

Products sold by SoCo Peptides are intended strictly for laboratory research purposes only.

These compounds are not intended for human consumption, veterinary use, household use, cosmetic use, or therapeutic application. They are not drugs, foods, or dietary supplements and have not been evaluated or approved by the FDA.

By purchasing from this website, the customer represents that they are a qualified researcher or laboratory professional and understand the risks associated with handling research materials.

All products must be handled by trained professionals in appropriate research facilities and in accordance with all applicable laws and regulations.

SoCo Peptides makes no guarantees or claims regarding safety, effectiveness, or medical benefit.